ריברוקסבאן אס.קיי. 10 מג
k.s.kim international (sk- pharma) ltd., israel - rivaroxaban - טבליות מצופות פילם - rivaroxaban 10 mg - rivaroxaban
ריברוקסבאן אס.קיי. 15 מג
k.s.kim international (sk- pharma) ltd., israel - rivaroxaban - טבליות מצופות פילם - rivaroxaban 15 mg - rivaroxaban
ריברוקסבאן אס.קיי. 20 מג
k.s.kim international (sk- pharma) ltd., israel - rivaroxaban - טבליות מצופות פילם - rivaroxaban 20 mg - rivaroxaban
ריברוקסבן תרו 2.5 מג
taro pharmaceutical industries ltd - rivaroxaban - טבליות מצופות פילם - rivaroxaban 2.5 mg - rivaroxaban
לשקוטאן משחה
teva israel ltd - methylbenzethonium chloride; paromomycin as sulfate - משחה - methylbenzethonium chloride 12 %w/w; paromomycin as sulfate 15 %w/w - paromomycin - paromomycin - topical treatment of cutaneous leishmaniasis.
טבעפירין
teva pharmaceutical industries ltd, israel - acetylsalicylic acid - טבליות עם ציפוי אנטרי - acetylsalicylic acid 100 mg - acetylsalicylic acid - acetylsalicylic acid - the primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.
טבעפירין
teva pharmaceutical industries ltd, israel - acetylsalicylic acid - טבליות עם ציפוי אנטרי - acetylsalicylic acid 100 mg - acetylsalicylic acid - acetylsalicylic acid - the primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.
קרדיופירין
dexcel ltd, israel - acetylsalicylic acid - טבליות עם ציפוי אנטרי - acetylsalicylic acid 100 mg - acetylsalicylic acid - acetylsalicylic acid - the primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.
גודמד 100 מג
gramse intrnational natural products limited partnership, israel - acetylsalicylic acid - טבליה - acetylsalicylic acid 100 mg - acetylsalicylic acid - acetylsalicylic acid - for inhibition of platelet aggregation
אינטגרילין 0.75 מגמל
merck sharp & dohme (israel - 1996) company ltd, israel - eptifibatide - תמיסה לאינפוזיה - eptifibatide 0.75 mg/ml - eptifibatide - eptifibatide - integrilin is indicated for the prevention of death and myocardial infarction in patients presenting with high risk unstable angina or non-q-wave myocardial infarction. integrilin is indicated in patients who are managed with standard medical therapies and/or with percutaneous coronary intervention. integrilin is also indicated as an adjunct to percutaneous transluminal coronary angioplasty (ptca) balloon angioplasty, directional atheretomy, transluminal extraction catheter atherectomy, rotational ablation angioplasty, or excimer laser angioplasty for the prevention of abrupt closure of the treated coronary vessel and related acute ischemic cardiac complications (death, myorardial infarction, need for urgent intervention). integrilin is intended for use with aspirin and heparin.